Randomized controlled trial shows improved treatment outcomes in recurrent non-muscle-invasive bladder cancer, suggesting less invasive options for patients.
Chemoresection reduces the need for surgical procedures in patients with recurrent NMIBC without compromising long-term oncological outcomes. These findings support its integration as a less-invasive treatment option in selected patients.
No takes yet. Share an insight, caveat, or question.
Klingenberg et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: